News & Media
Careers
Contact Us
""

Home
About Us
BUSINESSES
Foundation
Investor

News & Media Careers Contact Us

Home
About Us
Business
Foundation
investor

Privacy Policy
Disclaimer
© 2020 Piramal Enterprises Ltd.

Financial
Reports
Corporate
Governance
Shareholder
Information
Piramal
Pharma Day
Investor
Contacts

Shareholder Information
& Services

Investors
Shareholder Information
Scheme of Amalgamation

Shareholder Information

Shareholding
Pattern
Notice
Share
Capital
Dividend
Unclaimed
Dividend
Credit
Rating
PPMLD
Valuation
Forms
Announcements
Statement of
Employees
ESOP
Disclosure
Scheme of
Amalgamation
Rights
Issue

PEL – Merger final order
PEL - Newspaper Final Hearing Notice
Scrutinizers Report for Court Convened Meeting - 2nd April, 2019
PEL - Newspaper NCLT Notice
Notice - NCLT Meeting
Postal Ballot Form
Merger - Final Observation Letter - BSE
Merger - Final Observation Letter - NSE
Complaints Report
Application under Regulation 37 of the SEBI (LODR), Regulations, 2015 for the Scheme of Amalgamation
Draft Scheme of Amalgamation
Valuation Report
Report of the Audit Committee
Fairness Opinion Report
Auditor's Certificate
Detailed Compliance Report
Outcome of Board Meeting - Approval of draft Scheme of Amalgamation

Investor Presentation

PPL – Acquisition of Hemmo Pharmaceuticals

Quick Links

Annual Report – 2020-21
PPL – Acquisition of Hemmo Pharmaceuticals
Investor Calls
Transfer of shares in Demat Form

Investor Contacts
Press Releases
In The News

Piramal Group

Piramal Enterprises Ltd.
Piramal Realty
Piramal Foundation

Piramal Enterprises Ltd.

Piramal Pharma
– Pharma Solutions
– Critical Care
– Consumer Products

Financial Services
– Piramal Capital & Housing Finance Limited (PCHFL)
– India Resurgence Fund (IndiaRF)

Piramal Realty

– Piramal Mahalaxmi
– Piramal Aranya
– Piramal Revanta
– Piramal Vaikunth
– Piramal Agastya

Piramal Foundation

– Piramal Swasthya
– Piramal School of Leadership
– Piramal Sarvajal

© 2021 Piramal Enterprises Ltd.

Privacy Policy
Disclaimer